Schedule III isn’t the finish line.It’s the starting gun. The EO said a lot — but most operators aren’t ready for what it actually means. This week we sit down with Zach Edge and Dr. Matthew Moore to break down: Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators Which parts of the supply chain face the biggest disruption as cannabis moves forward Chapters 00:00 Historic Changes in Cannabis Scheduling 03:13 The Impact of Hemp in the New Landscape 06:07 Strategic Shifts for Cannabis Operators 08:59 Navigating Regulatory Changes 11:58 The Role of Pharmacies in the New Market 15:04 Global Trade and Competition in Cannabis 17:53 Research Opportunities and Challenges 21:02 Veterans and the Future of CBD 24:02 The Supply Chain Dynamics 26:47 The Future of Hemp and CBD Products 29:56 Final Thoughts on the Cannabis Industry Summary: In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves. Guest Links: https://www.linkedin.com/company/the-rho-advisory/ https://www.linkedin.com/in/zach-edge/ https://www.linkedin.com/in/mmoore09/ Our Links: Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/
Schedule III isn’t the finish line.
It’s the starting gun.
The EO said a lot — but most operators aren’t ready for what it actually means.
This week we sit down with Zach Edge and Dr. Matthew Moore to break down:
Chapters
00:00 Historic Changes in Cannabis Scheduling
03:13 The Impact of Hemp in the New Landscape
06:07 Strategic Shifts for Cannabis Operators
08:59 Navigating Regulatory Changes
11:58 The Role of Pharmacies in the New Market
15:04 Global Trade and Competition in Cannabis
17:53 Research Opportunities and Challenges
21:02 Veterans and the Future of CBD
24:02 The Supply Chain Dynamics
26:47 The Future of Hemp and CBD Products
29:56 Final Thoughts on the Cannabis Industry
Summary:
In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.
Guest Links:
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime
https://www.newton-insights.com/